FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

421026006: Conventional release oral tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616657012 Oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636015013 Conventional release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636016014 Conventional release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release oral tablet Is a Oral dose form true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Aripiprazole 30mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Emerres Una 1.5mg tablets (Morningside Healthcare Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nefopam 30mg tablets (Primegen Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Finasteride 1mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Trospium chloride 20mg tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Disulfiram 200mg tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lithium carbonate 250mg tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolfenamic acid 200mg tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Juliperla 75microgram / 20microgram tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Sofiperla 75microgram / 30microgram tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cistobil 500mg tablets (Imported (Italy)) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcium and Ergocalciferol tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Dexamethasone 2mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ferrous fumarate 322mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 10mg dispersible gastro-resistant tablets (DE Pharmaceuticals) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 20mg dispersible gastro-resistant tablets (DE Pharmaceuticals) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 40mg dispersible gastro-resistant tablets (DE Pharmaceuticals) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Calcium carbonate 1.25g tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin 250mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 100mg / Hydrochlorothiazide 25mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Meloxicam 7.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Meloxicam 15mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Rabeprazole 10mg gastro-resistant tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Rabeprazole 20mg gastro-resistant tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Rasagiline 1mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Repaglinide 500microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metoclopramide 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 400mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mianserin 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mianserin 30mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Minocycline 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Minocycline 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 30mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Modafinil 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Modafinil 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Montelukast 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Olanzapine 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Olanzapine 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 10mg dispersible gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 20mg dispersible gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Omeprazole 40mg dispersible gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Conventional release oral tablet Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Oxcarbazepine 150mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Oxcarbazepine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Oxcarbazepine 600mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pantoprazole 20mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pantoprazole 40mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Paracetamol 500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Paracetamol 500mg caplets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Phenytoin sodium 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets (Special Order) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mycophenolate mofetil 500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Naproxen 500mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Naproxen 500mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nebivolol 2.5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nitrazepam 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nitrofurantoin 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nitrofurantoin 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Norethisterone 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ofloxacin 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ofloxacin 400mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methocarbamol 750mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Primidone 50mg tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 50mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Paroxetine 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Phenoxymethylpenicillin 250mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Perindopril erbumine 4mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Perindopril erbumine 8mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pioglitazone 15mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pioglitazone 30mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pioglitazone 45mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pramipexole 700microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pramipexole 180microgram tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Prednisolone 1mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Prednisolone 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Prochlorperazine 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Procyclidine 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quetiapine 100mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quetiapine 150mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quetiapine 200mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quetiapine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quinapril 5mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quinapril 10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quinapril 20mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Quinapril 40mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 329 of 345 Next End


This concept is not in any reference sets

Back to Start